Literature DB >> 6401605

Effect of albumin concentration on the assay of serum free thyroxin by equilibrium radioimmunoassay with labeled thyroxin analog (Amerlex Free T4).

N Amino, K Nishi, K Nakatani, H Mizuta, K Ichihara, O Tanizawa, K Miyai.   

Abstract

Serum free thyroxin (FT4) in normal nonpregnant and pregnant subjects was measured by radioimmunoassay (RIA) with Amerlex FT4 RIA (Amersham International) and LiquiSol FT4 RIA (Damon Diagnostics) kits. Amerlex FT4 values in serum from pregnant women were lower than those in serum from nonpregnant women, but LiquiSol FT4 values were similar in serum from both groups. Amerlex FT4 values were directly correlated with the concentrations of albumin in serum and inversely correlated with those of thyroxin-binding globulin, but not with prealbumin concentrations. No significant correlations were observed between LiquiSol FT4 values and serum concentrations of thyroxin-binding proteins. Amerlex FT4 values were normal in patients with excess, deficient, or decreased thyroxin-binding globulin. Albumin added to serum samples increased Amerlex FT4 values but not LiquiSol FT4 values. Albumin inhibited the binding of labeled thyroxin analog to the solid-phase thyroxin antibody. These data indicate that the albumin concentration influences FT4 values as measured by an RIA involving a thyroxin analog and that Amerlex FT4 values should be carefully interpreted when the patient has an abnormal concentration of serum albumin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401605

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

Review 1.  Autoimmune thyroid disease and pregnancy.

Authors:  N Amino; H Tada; Y Hidaka
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

2.  Methodological aspects for free hormone estimation using microencapsulated antibody method--the effects of hormone binding protein on permeability of microcapsule membrane.

Authors:  T Hashimoto; K Ishibashi; F Matsubara
Journal:  Ann Nucl Med       Date:  1990-03       Impact factor: 2.668

3.  Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.

Authors:  H Tamaki; N Amino; Y Iwatani; K Miyai
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

4.  Aluminum-induced de novo bone formation in the beagle. A parathyroid hormone-dependent event.

Authors:  L D Quarles; H J Gitelman; M K Drezner
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Comparison of a new ultrafiltration method for serum free T4 and free T3 with two RIA kits in eight groups of patients.

Authors:  Y S Wang; A E Pekary; M L England; J M Hershman
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

6.  Familial dysalbuminemic hyperthyroxinemia (FDH): inadequacy of the "analog" methods for assaying free-T4 levels.

Authors:  P De Nayer; P Malvaux; C Beckers
Journal:  Eur J Nucl Med       Date:  1984

7.  Fatty acid induced changes in circulating total and free thyroid hormones: in vivo effects and methodological artefacts.

Authors:  W J Vermaak; W J Kalk; J M Kuyl; A M Smit
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

8.  Abnormalities of thyroid function tests in hospital inpatients.

Authors:  M C Sheppard; D B Ramsden
Journal:  Postgrad Med J       Date:  1985-11       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.